24 July 2020 : Database Analysis
Prognostic Value of Enolase Gene Family in Colon Cancer
Xiaohang Pan1AC, Huawen Wu1BF, Guofu Chen1EF, Wenhuan Li1AD*DOI: 10.12659/MSM.922980
Med Sci Monit 2020; 26:e922980
Table 1 Demographic and clinical data for 438 colon cancer patients.
| Variables | Patients (n=438) | No. of events (%) | MST (days) | HR (95% CI) | Log-rank P |
|---|---|---|---|---|---|
| Age (years) | 0.398 | ||||
| <60 | 122 | 81.1 | 3039 | Ref. | |
| ″60 | 316 | 76.3 | 2535 | 1.223 (0.766–1.952) | |
| Sex | 0.545 | ||||
| Female | 204 | 78.4 | 2990 | Ref. | |
| Male | 234 | 76.9 | 2320 | 1.131 (0.759–1.686) | |
| TNM stage | <0.001 | ||||
| I | 73 | 94.5 | 3234 | Ref. | |
| II | 167 | 83.8 | 2838 | 2.24 (0.781–6.421) | |
| III | 126 | 75.4 | 2856 | 4.068 (1.434–11.538) | |
| IV | 61 | 49.2 | 1114 | 11.291 (3.980–32.026) | |
| Missing | 11 | ||||
| MST – median survival time; HR – hazard ratio; CI – confidence interval. | |||||